Discover and read the best of Twitter Threads about #BLOODPRESSURE
Most recents (24)
1a) Welcome to a live-tweeted, #accredited #tweetorial from @nationallipid #NLA23 in #Atlanta on advances in #hyperlipidemia management #LLT. Our expert returning faculty is Pam R. Taub, MD @PamTaubMD #cardiologist from @UCSDHealth 
1b) Dr. Taub is a clinician/scientist and is a frequent contributor to our #accredited programs. She is the founding director of the Step Family Foundation Cardiac Rehabilitation and Wellness Center at #UCSD.
#FOAMed #cardiotwitter @MedTweetorials #MedEd #lipids
#FOAMed #cardiotwitter @MedTweetorials #MedEd #lipids
2) This program is supported by an educational grant from Esperion Therapeutics & is intended for #HCPs. Statement of accreditation & faculty disclosures at cardiometabolic-ce.com/disclosures/. Earn 0.75 hr 🆓CE/#CME by following this 🧵!
“The honking of horns and revving of engines doesn’t just affect those in the vehicles — it can also raise the #bloodpressure of people living near the road.” #trafficnoise #noisekills @CityofProv @PVDMayor @PVDCityCouncil @HealthyPVD @Brown_SPH @RIHealth cnn.com/2023/03/22/hea…
“Previous research had shown a connection between road #trafficnoise and an increased risk of #hypertension (#highbloodpressure), but it was still unclear whether it was the #noise or the pollution from the traffic that was the cause. Now, researchers say they have the evidence.”
“The results ... surprised researchers. People living near road #trafficnoise were not only more likely to develop #highbloodpressure, but the risk of this outcome increased with the ‘dose’ of #noise, even when researchers adjusted for fine particles and nitrogen dioxide.”
1) Welcome to a new #accredited #tweetorial in our series of educational programs on #hypertrophic #cardiomyopathy #HCM. Previous programs, still available for 🆓CE/#CME, are at cardiometabolic-ce.com/category/hcm/.
Now you can earn another 0.75hr credit by following this 🧵!
Now you can earn another 0.75hr credit by following this 🧵!
2) Our expert author is JA Linderbaum MS, ARNP, FACC, FPCNA @jlinderbaum, Associate Professor of Medicine, @MayoClinic, CV #NursePractitioner, Assoc. Medical Editor #AskMayoExpert.
#FOAMed #MedEd @MedTweetorials #CardioTwitter @transformingHC @TNPJ_Journal #cardiology
#FOAMed #MedEd @MedTweetorials #CardioTwitter @transformingHC @TNPJ_Journal #cardiology
3) This program is supported by an unrestricted educational grant from Bristol Myers-Squibb. Statement of accreditation and faculty disclosures at cardiometabolic-ce.com/disclosures/. Credit for #physicians #nursepractitioners #physicianassociates #nurses #pharmacists from @academiccme.
Why do people have persistent hypertension? Turns out there are many reasons; we developed a taxonomy to classify them so they can be addressed, based on #EHR data. @yuan_lu1 @CircOutcomes @SpatzErica @YaleMed @YaleCardiology #bloodpressure @AHAScience ahajournals.org/doi/abs/10.116…
@yuan_lu1 @CircOutcomes @SpatzErica @YaleMed @YaleCardiology @AHAScience Several years ago @yuan_lu1 and I introduced the concept of persistent hypertension to describe people with many measures of elevated #bloodpressure; a more encompassing term than resistant hypertension, which was about not responding to drugs. @amjmed sciencedirect.com/science/articl…
@yuan_lu1 @CircOutcomes @SpatzErica @YaleMed @YaleCardiology @AHAScience @amjmed We wrote that persistent hypertension was a condition of repetitive measures of above-goal elevated blood pressure over a period of time (eg, 6 mos), and drug resistance was just one of many causes. And many causes were related to missed opportunities in the care pathways.
🧵#BloodPressure 🎯 in people w/ cardiovascular disease
1/ In this updated @CochraneLibrary review, we wanted to know if lower bp goals are better than standard bp goals for ppl with #hypertension who also have CVD: buff.ly/3OmPT67
#CochraneEvidence #SystematicReview
1/ In this updated @CochraneLibrary review, we wanted to know if lower bp goals are better than standard bp goals for ppl with #hypertension who also have CVD: buff.ly/3OmPT67
#CochraneEvidence #SystematicReview
2/ The author team & an information specialist searched for studies:
✅ that compared lower #BloodPressure targets to standard bp🎯
✅ which included people with #hypertension and #CVD (heart disease, angina, stroke, vascular disease)
#SystematicReview #HighBloodPressure
✅ that compared lower #BloodPressure targets to standard bp🎯
✅ which included people with #hypertension and #CVD (heart disease, angina, stroke, vascular disease)
#SystematicReview #HighBloodPressure
3/ Trial selection criteria:
✅RCTs with more than 50 people/group
✅Minimum 6 months follow‐up
✅Data for at least 1 primary outcome (total mortality, serious adverse events, total cardiovascular events, cardiovascular mortality)
buff.ly/3OmPT67
✅RCTs with more than 50 people/group
✅Minimum 6 months follow‐up
✅Data for at least 1 primary outcome (total mortality, serious adverse events, total cardiovascular events, cardiovascular mortality)
buff.ly/3OmPT67
1a) Welcome to a new #accredited #tweetorial on a very challenging topic: managing #ICH in a patient taking anti-FXa #DOACs! Your expert authors are both #neurointensivists: Richard Choi, DO @rkchoi @christianacare and Casey Albin, MD @caseyalbin @EmoryNeuroCrit
1b) #Physicians #Nurses #Pharmacists #physicianassociate #NPs earn 0.5h CE/#CME from @academiccme for following this 🧵
2) This program is supported by an educational grant from AstraZeneca and is intended for #HCPs. Accreditation statement and faculty disclosures at cardiometabolic-ce.com/disclosures/. Prior (& future) programs in this space, available for 🆓CE/#CME credit, at cardiometabolic-ce.com/category/antit….
1) Welcome to a new #accredited #tweetorial, Update on New HFrEF Data from ESC 2022 with a Focus on Vericiguat. Our expert author is Giuseppe Galati MD, MMSc in Heart Failure, FHFA, @GiuseppeGalati_ , Consultant #Cardiologist #HeartFailure & #Cardiomyopathies
2) @GiuseppeGalati_ is at San Raffaele Research Hospital, Milan 🇮🇹 @SanRaffaeleMI. This program is intended for #healthcare professionals & is accredited for 0.75h CE/#CME credit for #physicians #physicianassistants #nurses #nursepractitioners #pharmacists.
3) This program is supported by an educational grant from Bayer. See archived programs still open for credit at cardiometabolic-ce.com. Statement of accreditation & faculty disclosures at cardiometabolic-ce.com/disclosures/.🙏 FOLLOW US !
This one found a high adipose tissue insulin resistance in normotensive individuals at baseline, as assessed by adipo-IR, to be associated (although weakly) with new-onset hypertension.
- In this study, the authors investigated the association between three insulin resistance indices (adipo-IR, HOMA-IR, and the Matsuda index) and hypertension in older Japanese individuals.
- In the cross-sectional analysis, all of these insulin resistance indices were statistically significantly associated with blood pressure levels.
This one finds that increased aldosterone levels may not necessarily lead to increased blood pressure.
- This is a translational inpatient trial deigned to elucidate the biological pathway leading from nutritional changes, through hormonal response, reversal of urine electrolytes ratio, to blood pressure reduction.
- Volunteers were admitted for 14 days, transitioning from a SAD to a DASH diet.
1) Welcome to our new #accredited #tweetorial which is Part 1 of a 2-part "highlights" program on new #SGLT2i & #DKD data presented at @ERAkidney #ERA22. #Physicians #nurses #pharmacists #PAs and #NPs can all earn 0.5h CE/#CME by following this thread!
2) @ERAkidney #ERA22 is a primary international scientific symposium for interaction and exchange among basic scientists and clinicians working in #Nephrology. It was held in May. Our expert author is Dr. Sheila Bermejo (@shbermejo) from @vallhebron in Barcelona, Spain.
3) This program is #accredited for CE/#CME & is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance. It is not intended for US- or UK-based based HCPs. Accreditation statement & faculty disclosures at ckd-ce.com/disclosures/.
I'm super excited to share the results of our phase 2 randomised clinical trial using gut microbial metabolites to lower #bloodpressure, for now as a pre-print
@VicHeartInst @MonashBiol @Monash_Science @MonashUni
Funded by @heartfoundation @nhmrc
A 🧵
medrxiv.org/cgi/content/sh…
@VicHeartInst @MonashBiol @Monash_Science @MonashUni
Funded by @heartfoundation @nhmrc
A 🧵
medrxiv.org/cgi/content/sh…
Work led by @HamdiAJama @dakotarrj in collaboration with many at @MonashUni and @BakerResearchAu inc @lab_nakai @RachelClimie @CreekLab @GeoffreyHead plus others not on Twitter
We started this work after our discovery in 2017 in mice that gut microbial metabolites explained the long-known association between high fibre intake and lower blood pressure and cardiovascular disease
We first tested acetate, published in @CircAHA
ahajournals.org/doi/full/10.11…
We first tested acetate, published in @CircAHA
ahajournals.org/doi/full/10.11…
6 reasons to take #BloodPressure in the MSK physiotherapy clinic.
A thread to ponder over Easter 🧵
#Haemodynamics #Physio #PhysicalTherapy #Hypertension
1/
A thread to ponder over Easter 🧵
#Haemodynamics #Physio #PhysicalTherapy #Hypertension
1/
Reason 1.
Vital signs tell you lots about the patient’s general health.
The 2 minutes it takes to check someone’s blood pressure may impact directly on your clinical reasoning and subsequent management.
2/
Vital signs tell you lots about the patient’s general health.
The 2 minutes it takes to check someone’s blood pressure may impact directly on your clinical reasoning and subsequent management.
2/
Reason 2.
High blood pressure is generally asymptomatic, so you wouldn’t know if the person sitting in front of you might be hypertensive.
... Unless you take the time to check.
3/
High blood pressure is generally asymptomatic, so you wouldn’t know if the person sitting in front of you might be hypertensive.
... Unless you take the time to check.
3/
1) Welcome to a new #accredited #tweetorial on Cardiorenal Disease in T2D & the Impact of Blocking the MR in Patients w/DKD, another CE/#CME program by one of the @GoggleDocs, this time our friend @AmarPut, Diabetes & Endocrine Consultant in the West Midlands 🇬🇧. #CaReMe #FOAMed
2) This program is supported by an educational grant from Bayer & is intended for #healthcare providers. Author disclosures can be found at ckd-ce.com/disclosures/. Prior programs, still available for CE/#CME credit, are at ckd-ce.com. CE/#CME credit 🇬🇧🇪🇺🇨🇦🇺🇸
3) So first – the ‘triple threat’ . . . We know of the link between the 🫀 and the kidneys and the ‘#cardiorenal’ syndrome, but what about in the setting of #diabetes?
1) Welcome to our new #tweetorial on optimizing #interprofessional & #multidisciplinary care & medical therapy for patients with #DKD. I am Sophia Ambruso DO, @Sophia_kidney, from @CU_kidney.
2) This #accredited #tweetorial series on #kidneydisease #DKD through the lens of #T2D is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance and is intended for healthcare providers. Faculty disclosures are at ckd-ce.com/disclosures/.
3) This activity is accredited for 0.75h credit for #physicians #physicianassociates #nurses #NPs #pharmacists. Past programs still eligible for credit can be found at ckd-ce.com. FOLLOW US for more programs by expert faculty!
1) Welcome to our new #accredited #tweetorial on #mechanismofaction & impact of meds commonly used in patients with or at risk for #DKD progression: #MRAs, #GLP-1 receptor agonists & #DPP-4 inhibitors. I am Sophia Ambruso DO, @sophia_kidney, from @CU_Kidney.
2) This #accredited #tweetorial series on #kidneydisease #DKD through the lens of #T2D is supported by an independent educational grant from the Boehringer Ingelheim/Lilly Alliance and is intended for healthcare providers.
3) This activity is accredited for #physicians #physicianassociates #nurses #NPs #pharmacists. Past programs still eligible for credit can be found at ckd-ce.com. Faculty disclosures are at ckd-ce.com/disclosures/. FOLLOW US for regular programs by expert faculty!
1) Welcome to a new #accredited #tweetorial on currently available treatments for mineralocorticoid receptor (MR) antagonism (#MRA), the differences among them, and how these differences impact on treatment of cardio-reno-metabolic diseases #CaReMe #FOAMed
2) Our expert author is Dr. Patrick Holmes MB BS, MSc, DipTher, MRCGP (@drpatrickholmes), a GP Partner at St. George’s Medical Practice, Darlington for 23 years. He is a Trustee for the Primary Care Diabetes Society and is Associate Editor for Diabetic Medicine @diabeticmed.
3) This program is supported by an educational grant from Bayer & is intended for #healthcare providers. Author disclosures can be found at ckd-ce.com/disclosures/. Prior programs, still available for CE/#CME credit, are at ckd-ce.com. CE/#CME credit 🇬🇧🇪🇺🇨🇦🇺🇸
THREAD: Primary #hypertension therapy: after thiazides, an ACEI or an ARB?
1/8 Nearly 650,000 British Columbians took an ACEI or ARB in 2021
Our new TI Therapeutics Letter reiterates evidence for one of the most common primary care tx choices: ti.ubc.ca/letter133
#MedEd
1/8 Nearly 650,000 British Columbians took an ACEI or ARB in 2021
Our new TI Therapeutics Letter reiterates evidence for one of the most common primary care tx choices: ti.ubc.ca/letter133
#MedEd
2/8 Lower #BloodPressure not the Main Goal
#Antihypertensives lower various measures of blood pressure (BP) 💊
But... not all BP lowering drugs are proven to reduce both morbidity & mortality
👉🏾ti.ubc.ca/letter133
#MedEd #prescribing #hypertension
#Antihypertensives lower various measures of blood pressure (BP) 💊
But... not all BP lowering drugs are proven to reduce both morbidity & mortality
👉🏾ti.ubc.ca/letter133
#MedEd #prescribing #hypertension
3/8 The importance of clinical outcomes
Basing decisions on which drug lowers #BloodPressure the best cannot guarantee the best clinical outcomes
Read our Therapeutics Letter on optimal 1st and 2nd line treatments: ti.ubc.ca/letter133
#MedEd #prescribing #hypertension
Basing decisions on which drug lowers #BloodPressure the best cannot guarantee the best clinical outcomes
Read our Therapeutics Letter on optimal 1st and 2nd line treatments: ti.ubc.ca/letter133
#MedEd #prescribing #hypertension
How #sleep loss may make physical #exercise more challenging for the #heart:
We find that sleep loss ⬆️ the exercise 🚴♀️-induced ⬆️ in blood levels of a #cardiac stress biomarker vs. after normal sleep
But note, exercise is essential for your health
🧵->
sciencedirect.com/science/articl…
We find that sleep loss ⬆️ the exercise 🚴♀️-induced ⬆️ in blood levels of a #cardiac stress biomarker vs. after normal sleep
But note, exercise is essential for your health
🧵->
sciencedirect.com/science/articl…
2/ Extensive epidemiological data has found that sleep impacts the risk of cardiovascular disease (CVD).
E.g. @uk_biobank (n~408k):
Vs. 7 h, sleep duration of ≤5 h & ≥9 h were associated with higher risk of CVD mortality & incidence (~+8-30%).
sciencedirect.com/science/articl…
E.g. @uk_biobank (n~408k):
Vs. 7 h, sleep duration of ≤5 h & ≥9 h were associated with higher risk of CVD mortality & incidence (~+8-30%).
sciencedirect.com/science/articl…
3/ And elegant human experimental studies have shown that curtailed #sleep can adversely impact🫀physiology.
For instance, shortened sleep can ⬆️ #bloodpressure in humans, seen both after overnight wakefulness academic.oup.com/sleep/article/… & shortened sleep ahajournals.org/doi/abs/10.116….
For instance, shortened sleep can ⬆️ #bloodpressure in humans, seen both after overnight wakefulness academic.oup.com/sleep/article/… & shortened sleep ahajournals.org/doi/abs/10.116….
(1) Welcome to this #accredited #tweetorial, on recent & emerging data on finerenone, a non-steroidal mineralocorticoid receptor antagonist. We’ll discuss what it is, what evidence supports its use, & where it might fit into future #renal guidelines. I am @drkevinfernando.
(2) This program is supported by an educational grant from Bayer and is intended for #healthcare providers. Author disclosures can be found at ckd-ce.com/disclosures/. Prior programs, still available for CE/#CME credit, are at ckd-ce.com.
(3) Let's start with a knowledge check.
The following therapeutic options have demonstrated a significant reduction in the progression of both #CKD and #cardiovascular mortality in people living with #T2D:
1. ACEi's & ARBs
2. Spironolactone
3. SGLT2 inhibitors
4. Finerenone
The following therapeutic options have demonstrated a significant reduction in the progression of both #CKD and #cardiovascular mortality in people living with #T2D:
1. ACEi's & ARBs
2. Spironolactone
3. SGLT2 inhibitors
4. Finerenone
1) Welcome to a new #accredited #tweetorial on the #goKDIGO guidance regarding evaluation and management of focal segmental glomerulosclerosis (#FSGS)--one of the most common causes of primary glomerular disease in adults. Leading us through this material is @edgarvlermamd.
2) Dr. Lerma is core faculty at both @ckd_ce & @cardiomet_CE and is an expert #nephrologist and #educator. This tweetorial is accredited for 0.5h CE/#CME for #physicians #nurses #NPs #PAs #pharmacists. Please follow along!
3) This educational program is supported by grants from Travere, Bayer, & Otsuka, and is intended for healthcare providers. Faculty disclosures can be found at ckd-ce.com/disclosures/. Past programs, still available for CE/#CME credit, are at ckd-ce.com.
Daily Bookmarks to GAVNet 12/14/2021 greeneracresvaluenetwork.wordpress.com/2021/12/14/dai…
As COVID's Omicron variant spreads, an Australian research team is 'very concerned' about discovery on its origins - ABC News
abc.net.au/news/2021-12-0…
#omicron, #COVID19, #variants, #transmissibility, #virulence, #GlobalControl
abc.net.au/news/2021-12-0…
#omicron, #COVID19, #variants, #transmissibility, #virulence, #GlobalControl
The Consequences of Moving from Industrial to Financial Capitalism – Consortium News
consortiumnews.com/2021/01/07/the…
#IndustrialCapitalism, #FinancialCapitalism, #consequences
consortiumnews.com/2021/01/07/the…
#IndustrialCapitalism, #FinancialCapitalism, #consequences
🔥Off the press: focused review on #race #ethnicity #hypertension #heartdisease w @KcfMd @ycommodore @JACCJournals #healthequity #bloodpressure #HTNroundtable #HTN80 #CardioTwitter #medtwitter @HHSGov @Surgeon_General @HeartNews @ABCardio1 @ACCinTouch
bit.ly/3rTMDG4
bit.ly/3rTMDG4
🩺#hypertension is the leading preventable #riskfactor for #heartdisease & #stroke
🩺#hypertension is a major contributor to #racial & #ethnic #disparities in #cardiovasculardisease
🩺#hypertension rates among #Black adults are one of the highest rates of globally
#HTNroundtable
🩺#hypertension is a major contributor to #racial & #ethnic #disparities in #cardiovasculardisease
🩺#hypertension rates among #Black adults are one of the highest rates of globally
#HTNroundtable
🩺#hypertension #control remains a persistent #clinical problem & #publichealth #challenge
🩺We must eliminate these #disparities in #HTN and address #barriers to #hypertensioncontrol
🩺#HTN80 #HTNroundtable #HealthEquity #bloodpressure #hypertensioncontrol
🩺We must eliminate these #disparities in #HTN and address #barriers to #hypertensioncontrol
🩺#HTN80 #HTNroundtable #HealthEquity #bloodpressure #hypertensioncontrol
Resistant #hypertension is elevated BP despite the use of 3 antihypertensive drugs. We now introduce persistent hypertension, a broader concept of persistently elevated blood pressure. @amjmed amjmed.com/article/S0002-… @YaleMed @YaleCardiology #BloodPressure
@amjmed @YaleMed @YaleCardiology Resistant hypertension focuses attention on those already treated with maximum doses; persistent hypertension is broader, those with persistently elevated blood pressure, for a wide range of reasons - and this is the vast majority who languish at high risk. @yuan_lu1 @amjmed
@amjmed @YaleMed @YaleCardiology @yuan_lu1 To make progress against hypertension we need to focus intently on those with persistent hypertension; high bp readings over time, without progress. There are so many reasons; and many are social in nature. And this burden falls hard on Black patients in particular.
Don’t miss a new accredited #tweetorial launching TOMORROW here on @cardiomet_CE. #Cardiologist, #SoMe education advocate, and true #Renaissance man @CMichaelGibson will be discussing a novel #aspirin prep that has PK/PD like plain #ASA . . .
. . . but a different site of absorption--with greater predictability than ECASA. DON'T MISS IT!! @DLBHATTMD @cpcannon @AnnMarieNavar @DrM_ODonoghue @DrMarthaGulati @practicalcardio @GuyattGH @DrMauricioCohen @SVRaoMD @ASPCardio @PlateletDoc @stephanamayer #FOAMed #CardioTwitter
1) Welcome to a #tweetorial where we’ll explore how changing the formulation of #aspirin & where it's absorbed in the GI tract can ⬇️the risk of acute GI injury, but still maintain predictable absorption. This program is accredited for 0.50h CE/#CME. I am @CMichaelGibson. #FOAMed
